The pharmaceutical giant Pfizer said on Monday that it had struck a $160 billion deal, including debt, to merge with Allergan, the maker of Botox, in one of the biggest takeovers in the health care industry.
The agreement would also be the biggest deal in what has been a banner year for mergers, driven in part by consolidation in the health care and pharmaceutical sectors. Merger and acquisition activity worldwide surpassed $4 trillion as of Thursday, for only the second time since Thomson Reuters began...
19:57 Kraft withdraws offer to merge with Unilever31
18:13 Warren Buffett's Shareholder Letter: 5 Lessons for All Investors15
15:45 Warren Buffett rails against fee-hungry Wall Street managers13
13:09 JCPenney shuttering up to 140 stores as sales weaken, more sluggish growth seen ahead15